nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—colon cancer	0.62	1	CbGaD
Lisinopril—ACE2—bile—colon cancer	0.0445	0.309	CbGeAlD
Lisinopril—ACE—vein—colon cancer	0.0135	0.0938	CbGeAlD
Lisinopril—ACE2—gall bladder—colon cancer	0.0123	0.0857	CbGeAlD
Lisinopril—ACE—umbilical vein—colon cancer	0.00981	0.0681	CbGeAlD
Lisinopril—ACE2—renal system—colon cancer	0.00592	0.0411	CbGeAlD
Lisinopril—ACE2—digestive system—colon cancer	0.00486	0.0337	CbGeAlD
Lisinopril—ACE—endothelium—colon cancer	0.00465	0.0323	CbGeAlD
Lisinopril—ACE2—vagina—colon cancer	0.00429	0.0298	CbGeAlD
Lisinopril—ACE—blood vessel—colon cancer	0.00429	0.0298	CbGeAlD
Lisinopril—ABCB1—Irinotecan—colon cancer	0.00417	0.416	CbGbCtD
Lisinopril—ABCB1—Vincristine—colon cancer	0.00364	0.364	CbGbCtD
Lisinopril—ACE2—liver—colon cancer	0.00362	0.0251	CbGeAlD
Lisinopril—SLC15A1—epithelium—colon cancer	0.00291	0.0202	CbGeAlD
Lisinopril—ACE2—lymph node—colon cancer	0.00277	0.0193	CbGeAlD
Lisinopril—SLC15A1—renal system—colon cancer	0.0027	0.0188	CbGeAlD
Lisinopril—ACE—embryo—colon cancer	0.00256	0.0178	CbGeAlD
Lisinopril—SLC15A1—digestive system—colon cancer	0.00221	0.0154	CbGeAlD
Lisinopril—ABCB1—Methotrexate—colon cancer	0.00221	0.22	CbGbCtD
Lisinopril—ACE—epithelium—colon cancer	0.00209	0.0145	CbGeAlD
Lisinopril—ACE—smooth muscle tissue—colon cancer	0.00201	0.014	CbGeAlD
Lisinopril—SLC15A1—vagina—colon cancer	0.00196	0.0136	CbGeAlD
Lisinopril—ACE—renal system—colon cancer	0.00194	0.0134	CbGeAlD
Lisinopril—SLC15A1—liver—colon cancer	0.00165	0.0115	CbGeAlD
Lisinopril—ACE—lymphoid tissue—colon cancer	0.00161	0.0112	CbGeAlD
Lisinopril—ACE—digestive system—colon cancer	0.00159	0.011	CbGeAlD
Lisinopril—ABCB1—blood vessel—colon cancer	0.00151	0.0105	CbGeAlD
Lisinopril—ACE—bone marrow—colon cancer	0.00146	0.0102	CbGeAlD
Lisinopril—ACE—liver—colon cancer	0.00118	0.00822	CbGeAlD
Lisinopril—ACE—lymph node—colon cancer	0.000907	0.0063	CbGeAlD
Lisinopril—ABCB1—embryo—colon cancer	0.0009	0.00625	CbGeAlD
Lisinopril—Nateglinide—PPARG—colon cancer	0.000851	0.446	CrCbGaD
Lisinopril—ABCB1—epithelium—colon cancer	0.000735	0.0051	CbGeAlD
Lisinopril—ABCB1—renal system—colon cancer	0.000681	0.00473	CbGeAlD
Lisinopril—Cilazapril—ABCB1—colon cancer	0.00061	0.319	CrCbGaD
Lisinopril—ABCB1—lymphoid tissue—colon cancer	0.000566	0.00393	CbGeAlD
Lisinopril—ABCB1—digestive system—colon cancer	0.000559	0.00388	CbGeAlD
Lisinopril—ABCB1—bone marrow—colon cancer	0.000515	0.00358	CbGeAlD
Lisinopril—ABCB1—vagina—colon cancer	0.000494	0.00343	CbGeAlD
Lisinopril—Enalapril—ABCB1—colon cancer	0.000448	0.234	CrCbGaD
Lisinopril—ABCB1—liver—colon cancer	0.000416	0.00289	CbGeAlD
Lisinopril—Osteoarthritis—Methotrexate—colon cancer	0.000326	0.00145	CcSEcCtD
Lisinopril—Confusional state—Irinotecan—colon cancer	0.000324	0.00144	CcSEcCtD
Lisinopril—Thrombocytopenia—Vincristine—colon cancer	0.000323	0.00144	CcSEcCtD
Lisinopril—Haematuria—Capecitabine—colon cancer	0.000322	0.00143	CcSEcCtD
Lisinopril—Anaphylactic shock—Irinotecan—colon cancer	0.000322	0.00143	CcSEcCtD
Lisinopril—Oedema—Irinotecan—colon cancer	0.000322	0.00143	CcSEcCtD
Lisinopril—Chest pain—Fluorouracil—colon cancer	0.000321	0.00143	CcSEcCtD
Lisinopril—Myalgia—Fluorouracil—colon cancer	0.000321	0.00143	CcSEcCtD
Lisinopril—Infection—Irinotecan—colon cancer	0.00032	0.00142	CcSEcCtD
Lisinopril—Hyperhidrosis—Vincristine—colon cancer	0.000319	0.00142	CcSEcCtD
Lisinopril—Hepatobiliary disease—Capecitabine—colon cancer	0.000319	0.00142	CcSEcCtD
Lisinopril—ABCB1—lymph node—colon cancer	0.000319	0.00222	CbGeAlD
Lisinopril—Epistaxis—Capecitabine—colon cancer	0.000318	0.00142	CcSEcCtD
Lisinopril—Discomfort—Fluorouracil—colon cancer	0.000318	0.00141	CcSEcCtD
Lisinopril—Shock—Irinotecan—colon cancer	0.000316	0.00141	CcSEcCtD
Lisinopril—Agranulocytosis—Capecitabine—colon cancer	0.000315	0.0014	CcSEcCtD
Lisinopril—Thrombocytopenia—Irinotecan—colon cancer	0.000315	0.0014	CcSEcCtD
Lisinopril—Anorexia—Vincristine—colon cancer	0.000315	0.0014	CcSEcCtD
Lisinopril—Irritability—Methotrexate—colon cancer	0.000311	0.00139	CcSEcCtD
Lisinopril—Hyperhidrosis—Irinotecan—colon cancer	0.000311	0.00138	CcSEcCtD
Lisinopril—Confusional state—Fluorouracil—colon cancer	0.000311	0.00138	CcSEcCtD
Lisinopril—Hypotension—Vincristine—colon cancer	0.000309	0.00137	CcSEcCtD
Lisinopril—Bradycardia—Capecitabine—colon cancer	0.000309	0.00137	CcSEcCtD
Lisinopril—Oedema—Fluorouracil—colon cancer	0.000308	0.00137	CcSEcCtD
Lisinopril—Anaphylactic shock—Fluorouracil—colon cancer	0.000308	0.00137	CcSEcCtD
Lisinopril—Anorexia—Irinotecan—colon cancer	0.000307	0.00137	CcSEcCtD
Lisinopril—Ataxia—Methotrexate—colon cancer	0.000307	0.00137	CcSEcCtD
Lisinopril—Infection—Fluorouracil—colon cancer	0.000306	0.00136	CcSEcCtD
Lisinopril—Rhinitis—Capecitabine—colon cancer	0.000304	0.00135	CcSEcCtD
Lisinopril—Hepatitis—Capecitabine—colon cancer	0.000303	0.00135	CcSEcCtD
Lisinopril—Thrombocytopenia—Fluorouracil—colon cancer	0.000302	0.00134	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Vincristine—colon cancer	0.000301	0.00134	CcSEcCtD
Lisinopril—Pharyngitis—Capecitabine—colon cancer	0.000301	0.00134	CcSEcCtD
Lisinopril—Tachycardia—Fluorouracil—colon cancer	0.000301	0.00134	CcSEcCtD
Lisinopril—Hypotension—Irinotecan—colon cancer	0.000301	0.00134	CcSEcCtD
Lisinopril—Urinary tract disorder—Capecitabine—colon cancer	0.000299	0.00133	CcSEcCtD
Lisinopril—Insomnia—Vincristine—colon cancer	0.000299	0.00133	CcSEcCtD
Lisinopril—Oedema peripheral—Capecitabine—colon cancer	0.000299	0.00133	CcSEcCtD
Lisinopril—Urethral disorder—Capecitabine—colon cancer	0.000297	0.00132	CcSEcCtD
Lisinopril—Paraesthesia—Vincristine—colon cancer	0.000297	0.00132	CcSEcCtD
Lisinopril—Breast disorder—Methotrexate—colon cancer	0.000295	0.00131	CcSEcCtD
Lisinopril—Anorexia—Fluorouracil—colon cancer	0.000294	0.00131	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000294	0.00131	CcSEcCtD
Lisinopril—Insomnia—Irinotecan—colon cancer	0.000291	0.0013	CcSEcCtD
Lisinopril—Paraesthesia—Irinotecan—colon cancer	0.000289	0.00129	CcSEcCtD
Lisinopril—Hypotension—Fluorouracil—colon cancer	0.000288	0.00128	CcSEcCtD
Lisinopril—Decreased appetite—Vincristine—colon cancer	0.000287	0.00128	CcSEcCtD
Lisinopril—Dyspnoea—Irinotecan—colon cancer	0.000287	0.00128	CcSEcCtD
Lisinopril—Erythema multiforme—Capecitabine—colon cancer	0.000287	0.00128	CcSEcCtD
Lisinopril—Somnolence—Irinotecan—colon cancer	0.000286	0.00127	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Vincristine—colon cancer	0.000285	0.00127	CcSEcCtD
Lisinopril—Fatigue—Vincristine—colon cancer	0.000285	0.00127	CcSEcCtD
Lisinopril—Dyspepsia—Irinotecan—colon cancer	0.000283	0.00126	CcSEcCtD
Lisinopril—Tinnitus—Capecitabine—colon cancer	0.000283	0.00126	CcSEcCtD
Lisinopril—Pain—Vincristine—colon cancer	0.000282	0.00126	CcSEcCtD
Lisinopril—Constipation—Vincristine—colon cancer	0.000282	0.00126	CcSEcCtD
Lisinopril—Asthma—Methotrexate—colon cancer	0.000282	0.00126	CcSEcCtD
Lisinopril—Flushing—Capecitabine—colon cancer	0.000281	0.00125	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000281	0.00125	CcSEcCtD
Lisinopril—Decreased appetite—Irinotecan—colon cancer	0.00028	0.00125	CcSEcCtD
Lisinopril—Eosinophilia—Methotrexate—colon cancer	0.000279	0.00124	CcSEcCtD
Lisinopril—Insomnia—Fluorouracil—colon cancer	0.000279	0.00124	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Irinotecan—colon cancer	0.000278	0.00124	CcSEcCtD
Lisinopril—Fatigue—Irinotecan—colon cancer	0.000277	0.00124	CcSEcCtD
Lisinopril—Paraesthesia—Fluorouracil—colon cancer	0.000277	0.00123	CcSEcCtD
Lisinopril—Pancreatitis—Methotrexate—colon cancer	0.000276	0.00123	CcSEcCtD
Lisinopril—Constipation—Irinotecan—colon cancer	0.000275	0.00123	CcSEcCtD
Lisinopril—Pain—Irinotecan—colon cancer	0.000275	0.00123	CcSEcCtD
Lisinopril—Angiopathy—Capecitabine—colon cancer	0.000275	0.00122	CcSEcCtD
Lisinopril—Dyspnoea—Fluorouracil—colon cancer	0.000275	0.00122	CcSEcCtD
Lisinopril—Somnolence—Fluorouracil—colon cancer	0.000274	0.00122	CcSEcCtD
Lisinopril—Mediastinal disorder—Capecitabine—colon cancer	0.000273	0.00122	CcSEcCtD
Lisinopril—Chills—Capecitabine—colon cancer	0.000272	0.00121	CcSEcCtD
Lisinopril—Dyspepsia—Fluorouracil—colon cancer	0.000271	0.00121	CcSEcCtD
Lisinopril—Arrhythmia—Capecitabine—colon cancer	0.000271	0.00121	CcSEcCtD
Lisinopril—Gastrointestinal pain—Vincristine—colon cancer	0.00027	0.0012	CcSEcCtD
Lisinopril—Decreased appetite—Fluorouracil—colon cancer	0.000268	0.00119	CcSEcCtD
Lisinopril—Alopecia—Capecitabine—colon cancer	0.000268	0.00119	CcSEcCtD
Lisinopril—Pancytopenia—Methotrexate—colon cancer	0.000268	0.00119	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000266	0.00118	CcSEcCtD
Lisinopril—Mental disorder—Capecitabine—colon cancer	0.000266	0.00118	CcSEcCtD
Lisinopril—Feeling abnormal—Irinotecan—colon cancer	0.000265	0.00118	CcSEcCtD
Lisinopril—Erythema—Capecitabine—colon cancer	0.000264	0.00117	CcSEcCtD
Lisinopril—Malnutrition—Capecitabine—colon cancer	0.000264	0.00117	CcSEcCtD
Lisinopril—Neutropenia—Methotrexate—colon cancer	0.000264	0.00117	CcSEcCtD
Lisinopril—Dysuria—Methotrexate—colon cancer	0.000264	0.00117	CcSEcCtD
Lisinopril—Pain—Fluorouracil—colon cancer	0.000263	0.00117	CcSEcCtD
Lisinopril—Gastrointestinal pain—Irinotecan—colon cancer	0.000263	0.00117	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Methotrexate—colon cancer	0.000262	0.00117	CcSEcCtD
Lisinopril—Body temperature increased—Vincristine—colon cancer	0.000261	0.00116	CcSEcCtD
Lisinopril—Abdominal pain—Vincristine—colon cancer	0.000261	0.00116	CcSEcCtD
Lisinopril—Flatulence—Capecitabine—colon cancer	0.00026	0.00116	CcSEcCtD
Lisinopril—Erectile dysfunction—Methotrexate—colon cancer	0.00026	0.00116	CcSEcCtD
Lisinopril—Dysgeusia—Capecitabine—colon cancer	0.000258	0.00115	CcSEcCtD
Lisinopril—Photosensitivity reaction—Methotrexate—colon cancer	0.000257	0.00115	CcSEcCtD
Lisinopril—Back pain—Capecitabine—colon cancer	0.000255	0.00114	CcSEcCtD
Lisinopril—Abdominal pain—Irinotecan—colon cancer	0.000254	0.00113	CcSEcCtD
Lisinopril—Body temperature increased—Irinotecan—colon cancer	0.000254	0.00113	CcSEcCtD
Lisinopril—Feeling abnormal—Fluorouracil—colon cancer	0.000254	0.00113	CcSEcCtD
Lisinopril—Muscle spasms—Capecitabine—colon cancer	0.000254	0.00113	CcSEcCtD
Lisinopril—Pneumonia—Methotrexate—colon cancer	0.000253	0.00113	CcSEcCtD
Lisinopril—Depression—Methotrexate—colon cancer	0.000251	0.00112	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000249	0.00111	CcSEcCtD
Lisinopril—Vision blurred—Capecitabine—colon cancer	0.000249	0.00111	CcSEcCtD
Lisinopril—Tremor—Capecitabine—colon cancer	0.000247	0.0011	CcSEcCtD
Lisinopril—Renal failure—Methotrexate—colon cancer	0.000247	0.0011	CcSEcCtD
Lisinopril—Ill-defined disorder—Capecitabine—colon cancer	0.000245	0.00109	CcSEcCtD
Lisinopril—Urticaria—Fluorouracil—colon cancer	0.000245	0.00109	CcSEcCtD
Lisinopril—Anaemia—Capecitabine—colon cancer	0.000244	0.00109	CcSEcCtD
Lisinopril—Body temperature increased—Fluorouracil—colon cancer	0.000244	0.00108	CcSEcCtD
Lisinopril—Hypersensitivity—Vincristine—colon cancer	0.000243	0.00108	CcSEcCtD
Lisinopril—Sweating—Methotrexate—colon cancer	0.000241	0.00107	CcSEcCtD
Lisinopril—Haematuria—Methotrexate—colon cancer	0.00024	0.00107	CcSEcCtD
Lisinopril—Malaise—Capecitabine—colon cancer	0.000238	0.00106	CcSEcCtD
Lisinopril—Hepatobiliary disease—Methotrexate—colon cancer	0.000238	0.00106	CcSEcCtD
Lisinopril—Epistaxis—Methotrexate—colon cancer	0.000237	0.00106	CcSEcCtD
Lisinopril—Vertigo—Capecitabine—colon cancer	0.000237	0.00106	CcSEcCtD
Lisinopril—Hypersensitivity—Irinotecan—colon cancer	0.000237	0.00106	CcSEcCtD
Lisinopril—Asthenia—Vincristine—colon cancer	0.000237	0.00106	CcSEcCtD
Lisinopril—Syncope—Capecitabine—colon cancer	0.000237	0.00105	CcSEcCtD
Lisinopril—Leukopenia—Capecitabine—colon cancer	0.000236	0.00105	CcSEcCtD
Lisinopril—Agranulocytosis—Methotrexate—colon cancer	0.000235	0.00104	CcSEcCtD
Lisinopril—Palpitations—Capecitabine—colon cancer	0.000233	0.00104	CcSEcCtD
Lisinopril—Loss of consciousness—Capecitabine—colon cancer	0.000232	0.00103	CcSEcCtD
Lisinopril—Asthenia—Irinotecan—colon cancer	0.000231	0.00103	CcSEcCtD
Lisinopril—Cough—Capecitabine—colon cancer	0.00023	0.00103	CcSEcCtD
Lisinopril—Hypersensitivity—Fluorouracil—colon cancer	0.000227	0.00101	CcSEcCtD
Lisinopril—Diarrhoea—Vincristine—colon cancer	0.000226	0.00101	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—colon cancer	0.000226	0.001	CcSEcCtD
Lisinopril—Myalgia—Capecitabine—colon cancer	0.000225	0.001	CcSEcCtD
Lisinopril—Arthralgia—Capecitabine—colon cancer	0.000225	0.001	CcSEcCtD
Lisinopril—Chest pain—Capecitabine—colon cancer	0.000225	0.001	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—colon cancer	0.000224	0.000997	CcSEcCtD
Lisinopril—Anxiety—Capecitabine—colon cancer	0.000224	0.000997	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000223	0.000993	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—colon cancer	0.000223	0.000992	CcSEcCtD
Lisinopril—Discomfort—Capecitabine—colon cancer	0.000222	0.000988	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—colon cancer	0.000221	0.000985	CcSEcCtD
Lisinopril—Diarrhoea—Irinotecan—colon cancer	0.00022	0.00098	CcSEcCtD
Lisinopril—Dry mouth—Capecitabine—colon cancer	0.00022	0.000978	CcSEcCtD
Lisinopril—Dizziness—Vincristine—colon cancer	0.000218	0.000973	CcSEcCtD
Lisinopril—Pruritus—Fluorouracil—colon cancer	0.000218	0.000971	CcSEcCtD
Lisinopril—Confusional state—Capecitabine—colon cancer	0.000217	0.000967	CcSEcCtD
Lisinopril—Oedema—Capecitabine—colon cancer	0.000215	0.000959	CcSEcCtD
Lisinopril—Infection—Capecitabine—colon cancer	0.000214	0.000953	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—colon cancer	0.000213	0.00095	CcSEcCtD
Lisinopril—Dizziness—Irinotecan—colon cancer	0.000213	0.000947	CcSEcCtD
Lisinopril—Shock—Capecitabine—colon cancer	0.000212	0.000943	CcSEcCtD
Lisinopril—Diarrhoea—Fluorouracil—colon cancer	0.000211	0.000939	CcSEcCtD
Lisinopril—Thrombocytopenia—Capecitabine—colon cancer	0.000211	0.000939	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—colon cancer	0.00021	0.000937	CcSEcCtD
Lisinopril—Tachycardia—Capecitabine—colon cancer	0.00021	0.000936	CcSEcCtD
Lisinopril—Vomiting—Vincristine—colon cancer	0.00021	0.000935	CcSEcCtD
Lisinopril—Skin disorder—Capecitabine—colon cancer	0.000209	0.000931	CcSEcCtD
Lisinopril—Rash—Vincristine—colon cancer	0.000208	0.000928	CcSEcCtD
Lisinopril—Hyperhidrosis—Capecitabine—colon cancer	0.000208	0.000927	CcSEcCtD
Lisinopril—Dermatitis—Vincristine—colon cancer	0.000208	0.000927	CcSEcCtD
Lisinopril—Headache—Vincristine—colon cancer	0.000207	0.000922	CcSEcCtD
Lisinopril—Anorexia—Capecitabine—colon cancer	0.000205	0.000914	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—colon cancer	0.000205	0.000912	CcSEcCtD
Lisinopril—Vomiting—Irinotecan—colon cancer	0.000205	0.000911	CcSEcCtD
Lisinopril—Dizziness—Fluorouracil—colon cancer	0.000204	0.000907	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—colon cancer	0.000203	0.000905	CcSEcCtD
Lisinopril—Rash—Irinotecan—colon cancer	0.000203	0.000903	CcSEcCtD
Lisinopril—Dermatitis—Irinotecan—colon cancer	0.000203	0.000902	CcSEcCtD
Lisinopril—Chills—Methotrexate—colon cancer	0.000202	0.000901	CcSEcCtD
Lisinopril—Headache—Irinotecan—colon cancer	0.000202	0.000897	CcSEcCtD
Lisinopril—Hypotension—Capecitabine—colon cancer	0.000201	0.000896	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—colon cancer	0.000199	0.000888	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—colon cancer	0.000198	0.00088	CcSEcCtD
Lisinopril—Erythema—Methotrexate—colon cancer	0.000196	0.000875	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—colon cancer	0.000196	0.000875	CcSEcCtD
Lisinopril—Nausea—Vincristine—colon cancer	0.000196	0.000874	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000196	0.000874	CcSEcCtD
Lisinopril—Vomiting—Fluorouracil—colon cancer	0.000196	0.000872	CcSEcCtD
Lisinopril—Insomnia—Capecitabine—colon cancer	0.000195	0.000867	CcSEcCtD
Lisinopril—Rash—Fluorouracil—colon cancer	0.000194	0.000865	CcSEcCtD
Lisinopril—Dermatitis—Fluorouracil—colon cancer	0.000194	0.000864	CcSEcCtD
Lisinopril—Paraesthesia—Capecitabine—colon cancer	0.000193	0.000861	CcSEcCtD
Lisinopril—Headache—Fluorouracil—colon cancer	0.000193	0.00086	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—colon cancer	0.000192	0.000856	CcSEcCtD
Lisinopril—Dyspnoea—Capecitabine—colon cancer	0.000192	0.000855	CcSEcCtD
Lisinopril—Nausea—Irinotecan—colon cancer	0.000191	0.000851	CcSEcCtD
Lisinopril—Back pain—Methotrexate—colon cancer	0.00019	0.000846	CcSEcCtD
Lisinopril—Dyspepsia—Capecitabine—colon cancer	0.00019	0.000844	CcSEcCtD
Lisinopril—Decreased appetite—Capecitabine—colon cancer	0.000187	0.000834	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Capecitabine—colon cancer	0.000186	0.000828	CcSEcCtD
Lisinopril—Fatigue—Capecitabine—colon cancer	0.000186	0.000827	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—colon cancer	0.000185	0.000824	CcSEcCtD
Lisinopril—Constipation—Capecitabine—colon cancer	0.000184	0.00082	CcSEcCtD
Lisinopril—Pain—Capecitabine—colon cancer	0.000184	0.00082	CcSEcCtD
Lisinopril—Nausea—Fluorouracil—colon cancer	0.000183	0.000815	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—colon cancer	0.000182	0.000811	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—colon cancer	0.000182	0.000808	CcSEcCtD
Lisinopril—Feeling abnormal—Capecitabine—colon cancer	0.000177	0.00079	CcSEcCtD
Lisinopril—Malaise—Methotrexate—colon cancer	0.000177	0.000789	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—colon cancer	0.000176	0.000786	CcSEcCtD
Lisinopril—Gastrointestinal pain—Capecitabine—colon cancer	0.000176	0.000784	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—colon cancer	0.000176	0.000783	CcSEcCtD
Lisinopril—Cough—Methotrexate—colon cancer	0.000171	0.000763	CcSEcCtD
Lisinopril—Urticaria—Capecitabine—colon cancer	0.000171	0.000762	CcSEcCtD
Lisinopril—Abdominal pain—Capecitabine—colon cancer	0.00017	0.000758	CcSEcCtD
Lisinopril—Body temperature increased—Capecitabine—colon cancer	0.00017	0.000758	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—colon cancer	0.000167	0.000745	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—colon cancer	0.000167	0.000745	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—colon cancer	0.000167	0.000745	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000166	0.000739	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—colon cancer	0.000165	0.000736	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—colon cancer	0.000162	0.00072	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—colon cancer	0.00016	0.000714	CcSEcCtD
Lisinopril—Infection—Methotrexate—colon cancer	0.000159	0.000709	CcSEcCtD
Lisinopril—Hypersensitivity—Capecitabine—colon cancer	0.000159	0.000706	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—colon cancer	0.000157	0.000699	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—colon cancer	0.000156	0.000693	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—colon cancer	0.000155	0.00069	CcSEcCtD
Lisinopril—Asthenia—Capecitabine—colon cancer	0.000154	0.000688	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—colon cancer	0.000153	0.00068	CcSEcCtD
Lisinopril—Pruritus—Capecitabine—colon cancer	0.000152	0.000678	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—colon cancer	0.00015	0.000667	CcSEcCtD
Lisinopril—Diarrhoea—Capecitabine—colon cancer	0.000147	0.000656	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000146	0.00065	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—colon cancer	0.000145	0.000646	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—colon cancer	0.000144	0.000641	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—colon cancer	0.000143	0.000636	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—colon cancer	0.000142	0.000635	CcSEcCtD
Lisinopril—Dizziness—Capecitabine—colon cancer	0.000142	0.000634	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—colon cancer	0.000141	0.000628	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—colon cancer	0.000139	0.00062	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—colon cancer	0.000138	0.000616	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—colon cancer	0.000138	0.000615	CcSEcCtD
Lisinopril—Pain—Methotrexate—colon cancer	0.000137	0.00061	CcSEcCtD
Lisinopril—Vomiting—Capecitabine—colon cancer	0.000137	0.00061	CcSEcCtD
Lisinopril—Rash—Capecitabine—colon cancer	0.000136	0.000605	CcSEcCtD
Lisinopril—Dermatitis—Capecitabine—colon cancer	0.000136	0.000604	CcSEcCtD
Lisinopril—Headache—Capecitabine—colon cancer	0.000135	0.000601	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—colon cancer	0.000132	0.000588	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—colon cancer	0.000131	0.000584	CcSEcCtD
Lisinopril—Nausea—Capecitabine—colon cancer	0.000128	0.00057	CcSEcCtD
Lisinopril—Urticaria—Methotrexate—colon cancer	0.000127	0.000567	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—colon cancer	0.000127	0.000564	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—colon cancer	0.000127	0.000564	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—colon cancer	0.000118	0.000526	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—colon cancer	0.000115	0.000512	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—colon cancer	0.000113	0.000505	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—colon cancer	0.00011	0.000488	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—colon cancer	0.000106	0.000472	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—colon cancer	0.000102	0.000454	CcSEcCtD
Lisinopril—Rash—Methotrexate—colon cancer	0.000101	0.00045	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—colon cancer	0.000101	0.00045	CcSEcCtD
Lisinopril—Headache—Methotrexate—colon cancer	0.0001	0.000447	CcSEcCtD
Lisinopril—Nausea—Methotrexate—colon cancer	9.52e-05	0.000424	CcSEcCtD
